Stock listing

Copenhagen:ALKB ALK-abello A/S Aktie

Home listing (Copenhagen) of ALK-abello A/S

Follow ALK-abello A/S into a list and get an email when it puts out news.

Share price · OMXCOP:ALK_B

239.20 DKK -3.80 (-1.6%)

Close on Nov 20, 2026

Past year +3.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
238.60 – 244.00 DKKNov 20, 2026
Volume
201,585 sharesNov 20, 2026
Market cap
48.16B DKKAt the close on Nov 20, 2026 · price × 201.3M shares outstanding
52-week range
191.80 – 271.40 DKKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
52.26M DKKMedian day 205,784 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
ALK-abello A/S logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
OTC:AKBLF$36.50 USD0.00 (0.0%)—$36.50$36.50$36.50$36.50Close on Nov 6, 2026
Frankfurt:4AJ0€32.34 EUR-0.10 (-0.3%)—€32.34€32.34€32.34€32.44Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXCOP:ALK_B · DKK, adjusted for splits

DayCloseChange%OpenHighLowVolume
239.20-3.80-1.6%243.80244.00238.60201,585
243.00-3.00-1.2%246.60248.00239.40357,193
246.00-7.20-2.8%250.00251.80229.00422,497
253.20+4.80+1.9%248.40253.60248.00252,835
248.40-0.40-0.2%249.00250.00247.60100,659
248.80+1.00+0.4%248.60250.80246.80181,689
247.80+2.20+0.9%246.60248.40245.20128,195
245.60+2.80+1.2%244.60245.80241.80211,293
242.80-3.60-1.5%243.60244.40240.00121,558
246.40+2.80+1.1%244.40248.00244.40155,238
243.60-3.20-1.3%246.60248.00243.60177,049
246.80+1.60+0.7%244.80247.20242.20150,403
245.20-2.80-1.1%246.00248.20245.20116,653
248.00+1.40+0.6%250.00252.00246.40137,802
246.60+3.00+1.2%244.00247.40241.40294,653
243.60+0.20+0.1%242.60244.40240.60147,088
243.40+1.60+0.7%241.80243.60240.60162,118
241.80-1.00-0.4%243.20245.60241.20149,725
242.80+2.20+0.9%241.20243.40237.40156,341
240.60-2.00-0.8%243.00243.20239.40126,480
242.60+4.80+2.0%239.00243.80239.00257,796
237.80+0.80+0.3%238.80239.20236.80232,917
237.00+9.60+4.2%228.80238.20227.60400,301
227.40-5.40-2.3%231.60232.40226.60148,850
232.80+6.80+3.0%226.00232.80226.00253,054
226.00-1.20-0.5%226.60228.20224.40219,799
227.20-0.80-0.4%228.00231.80225.40223,185
228.00+0.60+0.3%227.00231.00225.00281,950
227.40-0.80-0.4%228.20229.80224.80251,746
228.20+10.20+4.7%232.80235.80228.00575,593
218.00+11.00+5.3%213.20219.20211.00351,244
207.00+4.60+2.3%205.00211.00205.00349,035
202.40+0.80+0.4%201.60206.80201.60195,116
201.60+4.10+2.1%197.40204.00196.30219,254
197.50-0.90-0.5%197.50199.30194.10246,820
198.40+2.10+1.1%196.10200.20196.00201,186
196.30-4.70-2.3%201.00201.20196.30236,162
201.00+1.30+0.7%199.30201.00197.80185,243
199.70+2.90+1.5%196.50199.70195.60198,183
196.80-1.20-0.6%196.90199.20196.70150,535
198.00-3.00-1.5%200.00204.00198.00251,653
201.00+1.90+1.0%199.10201.60198.50145,994
199.10+0.60+0.3%198.50199.60196.20183,936
198.50-0.50-0.3%200.00200.00197.10303,815
199.00+4.90+2.5%193.70199.00192.50224,542
194.10+1.80+0.9%192.90195.00192.30164,214
192.30-2.90-1.5%195.00195.20191.80235,025
195.20-0.70-0.4%196.80198.00194.60180,801
195.90-3.30-1.7%199.20199.40195.90184,693
199.20-0.80-0.4%199.40202.80198.60228,842
200.00-4.60-2.2%204.40204.60198.20265,195
204.60-1.40-0.7%206.60207.20204.2081,652
206.00-2.80-1.3%207.60208.00205.8097,716
208.80-0.40-0.2%209.20210.40208.60140,207
209.20-0.80-0.4%210.00213.60209.20156,538
210.00-0.80-0.4%210.80213.00209.00311,929
210.80+2.00+1.0%208.00210.80205.20285,857
208.80+0.20+0.1%208.00211.00208.00383,782
208.60-3.60-1.7%212.20213.60208.00200,709
212.20+2.00+1.0%210.00214.00208.60205,784
210.20+1.40+0.7%208.20211.80206.60431,895
208.80-5.40-2.5%214.20216.20208.80682,389
214.20-1.80-0.8%216.80217.80212.00173,619
216.00+7.00+3.3%212.80216.00207.60368,324
209.00-14.60-6.5%227.00228.40208.40648,552

Splits

4 splits since 1992 · OMXCOP:ALK_B · every price before a split is adjusted for it

DayRatioWhat
20-for-1Split
2-for-1Split
5-for-1Split
39-for-37Split
Ticker
Copenhagen:ALK_B
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
Copenhagen
Currency
DKK

What changed lately

Latest news

All ALK-abello A/S news

ALK-abello A/S on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
13 in the last 12 months · 27 in all · newest May 4, 2026 · oldest 2025
Calls
10 calls with a replay · 10 with a transcript · latest Aug 20, 2026
Decks
14 decks · latest Aug 20, 2026

Where ALK-abello A/S is listed

ListingExchangeCountryCurrency
Copenhagen:ALKB · Home listing · This pageCopenhagenDenmarkDKK
OTC:AKBLFOTCUnited StatesUSD
Tradegate:4AJ0TradegateGermanyEUR
gettex:4AJ0gettexGermanyEUR
VIE:ALKBViennaAustriaEUR
Aquis:ALKBCAquisUnited KingdomDKK
Stuttgart:4AJ0StuttgartGermanyEUR
LS Exchange:A3DHX9LS ExchangeGermanyEUR
Lang & Schwarz:A3DHX9Lang & SchwarzGermanyEUR
LSIN:0OIRLSINUnited KingdomDKK
Frankfurt:4AJ0FrankfurtGermanyEUR
Turquoise:ALKBCTurquoiseUnited KingdomDKK
Aquis:ALKBCAquisUnited KingdomDKK
Munich:4AJ0MunichGermanyEUR
Dusseldorf:4AJ0DusseldorfGermanyEUR
Hamburg:4AJ0HamburgGermanyEUR
Hanover:4AJ0HanoverGermanyEUR
Xetra:4AJ0XetraGermanyEUR

Valuation

P/E 34.3× against a median of 18.7×: 7th lowest of 9 Pharmaceuticals companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
46.49B DKK
P/E
34.3×
EV/sales
6.6×
EV/EBITDA
20.9×
Price/book
6.6×
Gross margin
68.0%
Operating margin
26.5%
Net margin
19.9%
Debt to equity
0.1×
Beta
No index for this market yet

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
ALK-abello A/S Class B · OMXCOP:ALK_BUS$7.07BUS$6.82B34.3×6.6×20.9×6.6×19.9%0.1×n/a
Rhythm Pharmaceuticals, Inc. · NASDAQ:RYTMUS$7.79BUS$7.57Bn/a27.0×n/a88.6×−69.0%1.2×1.20
Amneal Pharmaceuticals, Inc. · NASDAQ:AMRXUS$7.36BUS$10.14B55.2×3.2×16.0×13.8×4.2%5.5×0.67
Chemical Works of Gedeon Richter PLC · BET:RICHTERUS$7.13BUS$6.29B10.4×2.3×5.6×1.8×25.0%0.0×n/a
Corcept Therapeutics Incorporated · NASDAQ:CORTUS$6.88BUS$6.52B42.4×6.8×57.2×8.3×16.8%0.0×1.59
Alkem Laboratories Ltd. · NSE:ALKEMUS$6.69BUS$6.78B30.0×4.0×20.0×4.2×13.2%0.2×n/a
Huadong Medicine Co., Ltd. Class A · SZSE:000963US$6.53BUS$5.95B12.7×0.9×n/a1.7×7.8%0.0×n/a
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class A · SZSE:000999US$6.48BUS$5.85B13.4×1.3×n/a1.9×10.4%0.1×n/a
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class A · SSE:600196US$6.44BUS$6.39B12.2×1.0×n/a0.8×8.2%0.3×n/a
Mirum Pharmaceuticals, Inc. · NASDAQ:MIRMUS$6.28BUS$6.65Bn/a9.9×n/an/a−134.8%n/a0.83
Apotex Health Corp. · TSX:APTXUS$6.23BUS$7.67B23.9×3.1×11.8×25.5×10.7%6.7×n/a
Median of the othersUS$6.61BUS$6.58B18.7×3.2×16.0×4.2×9.3%0.2×1.01

Forecasts

Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
289.67 DKK · Analysts' mean
EPS, year to Dec 2026
6.89 · 6 analysts
Revenue, year to Dec 2026
7.36B · 6 analysts

Team and board

Officers

OfficerRole
Peter HallingPresident & CEO
Claus Steensen SøljeExecutive Vice President & CFO
Christian G. HoughtonExecutive Vice President, Product Supply
Edward JordanExecutive Vice President, Commercial Operations North America
Flora Beiche-ScholzExecutive Vice President, Commercial Operations Europe
Jacob GlentingEVP Global Research & Development
Jan EngelSenior Vice President, Global Quality
Lika ThiesenExecutive Vice President, Global People & Organisation
Tina Abild OlesenEVP Corporate, Portfolio and Product Strategy

Board

DirectorRole
Anders HedegaardChair of the Board
Alan MainBoard member
Bertil LindmarkBoard member
Gitte AaboBoard member
Jesper HøilandIndependent Director
Johan SmedsrudBoard member
Katja BarnkobBoard Member
Lars HolmqvistBoard member
Lene SkoleVice Chair
Lise Lund MærkedahlBoard member
Nanna CarlsonBoard Member

Events

Next results
Feb 9, 2027 (expected)

Results days

QuarterResultsShare move
Q3 2026Nov 17, 2026 · Before open−2.8%
Q2 2026Aug 20, 2026 · Before open−6.5%
Q1 2026May 4, 2026 · Before open+7.0%
Q4 2025Feb 20, 2026 · Before open−2.5%
Q3 2025Nov 12, 2025 · After close+11.5%
Q2 2025Aug 21, 2025+11.2%
Q1 2025May 6, 2025 · Before open+4.7%
Q4 2024Feb 19, 2025 · After close−5.2%
Q3 2024Nov 14, 2024 · Before open+6.0%
Q2 2024Aug 22, 2024 · After close+12.2%
All 20 quarters
QuarterResultsShare move
Q1 2024May 2, 2024 · After close+13.6%
Q4 2023Feb 8, 2024 · Before open+8.1%
Q3 2023Nov 15, 2023 · Before open+16.7%
Q2 2023Aug 24, 2023 · Before open+7.0%
Q1 2023May 9, 2023 · Before open+2.0%
Q4 2022Feb 3, 2023 · Before open+9.5%
Q3 2022Nov 10, 2022 · Before open−9.1%
Q2 2022Aug 11, 2022 · Before open+7.8%
Q1 2022May 12, 2022 · Before open−3.1%
Q4 2021Feb 8, 2022 · Before open−3.4%

Open Events

Decks

DeckKindSlidesDate
Q2 2026 Earnings PresentationEarnings10 slidesAug 20, 2026
Q1 2026 Earnings PresentationEarnings11 slidesMay 4, 2026
Alk-Abello As B Shs New — FY2025 Earnings PresentationEarnings17 slidesMay 4, 2026
Alk-Abello As B Shs New — Q4 2025 Earnings PresentationEarnings12 slidesFeb 20, 2026
Alk-Abello As B Shs New — Q3 2025 Earnings PresentationEarnings10 slidesNov 13, 2025
Alk-Abello As B Shs New — Q2 2025 Earnings PresentationEarnings12 slidesAug 21, 2025
Alk-Abello As B Shs New — Q1 2025 Earnings PresentationEarnings12 slidesMay 6, 2025
Alk-Abello As B Shs New — Q4 2024 Earnings PresentationEarnings12 slidesFeb 19, 2025
Alk-Abello As B Shs New — Q3 2024 Earnings PresentationEarnings11 slidesNov 14, 2024
Alk-Abello As B Shs New — Q2 2024 Earnings PresentationEarnings12 slidesAug 23, 2024
All 14 decks
DeckKindSlidesDate
Alk-Abello As B Shs New — Q1 2024 Earnings PresentationEarnings12 slidesMay 3, 2024
FY2022 Earnings PresentationEarnings14 slidesFeb 3, 2023
Symposium on Specific Allergy (eSOSA) 2021Conference13 slidesJune 2021
Non-Deal Roadshow (February 2019)Roadshow25 slidesFebruary 2019

Open Decks

Financials

Annual, in DKK

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue6.31B5.54B4.82B4.51B3.92B3.49B3.27B2.92B2.91B3.00B
Cost of revenue2.08B1.99B1.79B1.72B1.52B1.46B1.38B1.28B1.27B1.01B
Gross profit4.23B3.55B3.04B2.79B2.40B2.03B1.89B1.63B1.64B2.00B
Research and development609.0M531.0M618.0M665.0M631.0M515.0M466.0M392.0M426.0M385.0M
Selling, general and administrative1.90B369.0M331.0M276.0M240.0M237.0M246.0M227.0M231.0M230.0M
Operating income1.65B1.09B666.0M470.0M292.0M150.0M-14.0M-96.0M-80.0M479.0M
Depreciation and amortization328.0M272.0M245.0M238.0M242.0M245.0M255.0M232.0M333.0M163.0M
EBITDA1.98B1.36B911.0M708.0M534.0M395.0M241.0M136.0M253.0M642.0M
Interest expense47.0M95.0M22.0M24.0M23.0M34.0M39.0M25.0M16.0M14.0M
Income before tax1.64B1.06B647.0M447.0M279.0M101.0M-31.0M-103.0M-122.0M487.0M
Income tax438.0M242.0M161.0M112.0M60.0M76.0M19.0M67.0M36.0M217.0M
Net income1.20B815.0M486.0M335.0M219.0M25.0M-50.0M-170.0M-158.0M270.0M
Earnings per share, basic540.003.682.201.510.990.11-0.23-0.78-0.791.36
Earnings per share, diluted540.003.68

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents1.24B589.0M474.0M221.0M194.0M298.0M316.0M296.0M162.0M292.0M
Short-term investments-160.0M100.0M549.0M548.0M
Receivables1.09B812.0M890.0M864.0M677.0M660.0M656.0M469.0M424.0M383.0M
Inventory1.78B1.72B1.42B1.30B1.20B1.09B1.06B993.0M875.0M676.0M
Current assets4.49B3.29B2.97B2.65B2.40B2.34B2.25B2.00B2.15B1.95B
Property, plant and equipment2.26B2.35B2.02B1.81B1.70B1.74B1.58B1.58B1.63B
Goodwill455.0M463.0M459.0M460.0M457.0M452.0M461.0M465.0M461.0M422.0M
Total assets9.06B8.25B6.73B6.31B5.83B5.56B5.50B4.87B4.96B4.80B
Accounts payable140.0M165.0M128.0M131.0M115.0M74.0M81.0M135.0M121.0M132.0M
Current liabilities1.33B1.95B1.31B1.40B1.39B1.03B934.0M726.0M666.0M807.0M
Long-term debt151.0M166.0M184.0M203.0M222.0M686.0M707.0M725.0M741.0M758.0M
Total debt418.0M1.19B765.0M696.0M710.0M943.0M990.0M742.0M758.0M775.0M
Total liabilities2.61B2.87B2.28B2.32B2.35B2.41B2.32B1.69B1.67B1.92B
Shareholders' equity6.45B5.37B4.45B3.99B3.48B3.15B3.18B3.18B3.29B2.88B
Shares outstanding221.8M221.5M221.3M221.4M221.0M219.9M218.0M218.2M199.3M198.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations1.82B1.21B667.0M416.0M468.0M301.0M132.0M-95.0M-387.0M405.0M
Capital spending-276.0M-260.0M-379.0M-298.0M-263.0M-222.0M-167.0M-178.0M-267.0M-225.0M
Free cash flow1.54B953.0M288.0M118.0M205.0M79.0M-35.0M-273.0M-654.0M180.0M
Cash from investing-385.0M-1.42B-375.0M-351.0M-266.0M-245.0M-157.0M-199.0M-358.0M-204.0M
Cash from financing-760.0M310.0M-31.0M-42.0M-311.0M-62.0M-57.0M-28.0M620.0M39.0M
Dividends paid-51.0M-49.0M
Share buybacks-26.0M-38.0M-24.0M-24.0M-18.0M702.0M47.0M
Change in cash672.0M106.0M253.0M27.0M-104.0M-18.0M-80.0M-315.0M-129.0M232.0M

Open Financials

Cap table

Built by 6ix from ALK-abello A/S Class B’s releases

Common shares
201,327,842
Fully diluted
201,327,842

Fully diluted

LineShares
Common shares201,327,842

Share count over time

CountShares
Nov 22, 2026201,327,842

Open Cap table

Shareholders

HolderSharesValueAs of
Vanguard Total International Stock Index Fund1.92MUS$65.7MJul 31, 2026
Vanguard Developed Markets Index Fund1.29MUS$48.3MJun 30, 2026
iShares Core MSCI EAFE ETF997KUS$34.1MJul 31, 2026
The Continental Small Company Series724KUS$24.8MJul 31, 2026
Vanguard Ftse All-World Ex-Us Small-Cap Index Fund503KUS$17.2MJul 31, 2026
International Core Equity 2 Portfolio501KUS$17.1MJul 31, 2026
iShares MSCI EAFE Small-Cap ETF485KUS$16.6MJul 31, 2026
Artisan International Small-Mid Fund354KUS$13.2MJun 30, 2026
Vanguard European Stock Index Fund315KUS$10.8MJul 31, 2026
Invesco International Small Company Fund305KUS$11.4MJun 30, 2026
All 103 holders
HolderSharesValueAs of
Schwab International Small-Cap Equity ETF276KUS$11.5MMay 31, 2026
Rainier International Discovery Series240KUS$8.22MJul 31, 2026
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF205KUS$7.66MJun 30, 2026
iShares Core MSCI Total International Stock ETF194KUS$6.64MJul 31, 2026
iShares Core MSCI International Developed Markets ETF170KUS$5.81MJul 31, 2026
International Small-Mid Cap Fund160KUS$6.7MMay 31, 2026
Dimensional International Small Cap ETF151KUS$5.15MJul 31, 2026
Dimensional International Core Equity 2 ETF124KUS$4.23MJul 31, 2026
Vanguard Total World Stock Index Fund106KUS$3.62MJul 31, 2026
Vanguard International Explorer Fund105KUS$3.58MJul 31, 2026
Oneascent International Equity ETF99,710US$4.17MMay 31, 2026
College Retirement Equities Fund - Total Global Stock Account95,361US$3.57MJun 30, 2026
Alger International Opportunities Fund92,801US$3.17MJul 31, 2026
iShares MSCI Denmark ETF88,327US$3.69MMay 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF84,416US$2.88MJul 31, 2026
JNL Multi-Manager International Small Cap Fund82,419US$3.08MJun 30, 2026
Lord Abbett International Opportunities Fund82,000US$2.8MJul 31, 2026
iShares Core MSCI Europe ETF79,158US$2.71MJul 31, 2026
Fidelity Total International Index Fund76,458US$2.62MJul 31, 2026
Old Westbury Small & Mid Cap Strategies Fund74,837US$2.56MJul 31, 2026
Siit World Equity Ex-Us Fund69,134US$2.89MMay 31, 2026
WCM International Small Cap Growth Fund65,303US$2.44MJun 30, 2026
Dimensional International Core Equity Market ETF63,288US$2.16MJul 31, 2026
William Blair International Growth Fund61,275US$2.29MJun 30, 2026
Fidelity SAI International Quality Index Fund55,705US$1.91MJul 31, 2026
Clearwater International Fund52,327US$1.96MJun 30, 2026
Fidelity Nordic Fund51,600US$1.77MJul 31, 2026
International Sustainability Core 1 Portfolio47,747US$1.63MJul 31, 2026
Invesco Global Small Cap Equity Fund46,806US$1.75MJun 30, 2026
Driehaus International Small Cap Growth Fund44,274US$1.66MJun 30, 2026
World ex U.S. Core Equity Portfolio43,956US$1.5MJul 31, 2026
Large Cap International Portfolio41,138US$1.41MJul 31, 2026
William Blair Institutional International Growth Fund41,104US$1.53MJun 30, 2026
Avantis International Equity ETF40,237US$1.68MMay 31, 2026
Fidelity SAI International Small Cap Index Fund39,053US$1.34MJul 31, 2026
International Vector Equity Portfolio38,478US$1.32MJul 31, 2026
William Blair International Small Cap Growth Fund36,034US$1.35MJun 30, 2026
State Street Global All Cap Equity ex-U.S. Index Portfolio34,157US$1.28MJun 30, 2026
International Social Core Equity Portfolio32,141US$1.1MJul 31, 2026
Voya Multi-Manager International Small Cap Fund31,503US$1.08MJul 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Edward Jordan
Other companies: DBV Technologies SA (EVP and head of Commercial Operations North America · Since at least Dec 1, 2025); Teva Pharmaceutical Industries Limited (EVP and head of Commercial Operations North America · Since at least Dec 1, 2025)
Executive Vice President, Commercial Operations North America · Since at least Dec 1, 2025
Alan MainBoard member · Since at least Nov 5, 2026
Anders HedegaardChair of the Board · Since at least Nov 5, 2026
Bertil LindmarkBoard member · Since at least Nov 5, 2026
Christian G. HoughtonExecutive Vice President, Product Supply · Since at least Nov 5, 2026
Claus Steensen SøljeExecutive Vice President & CFO · Since at least Apr 28, 2026
Flora Beiche-ScholzExecutive Vice President, Commercial Operations Europe · Since at least Sep 4, 2025
Gitte AaboBoard member · Since at least Nov 5, 2026
Jacob GlentingEVP Global Research & Development · Since at least Nov 5, 2026
Jan EngelSenior Vice President, Global Quality · Since at least Nov 5, 2026
All 20 people
PersonSeat
Jesper HøilandIndependent Director · Since at least Nov 4, 2026
Johan SmedsrudBoard member · Since at least Nov 5, 2026
Katja BarnkobBoard Member · Since at least Nov 5, 2026
Lars HolmqvistBoard member · Since at least Nov 5, 2026
Lene SkoleVice Chair · Since at least Nov 5, 2026
Lika ThiesenExecutive Vice President, Global People & Organisation · Since at least Nov 5, 2026
Lise Lund MærkedahlBoard member · Since at least Nov 5, 2026
Nanna CarlsonBoard Member · Since at least Nov 5, 2026
Peter HallingPresident & CEO · Since at least Apr 28, 2026
Tina Abild OlesenEVP Corporate, Portfolio and Product Strategy · Since at least Nov 4, 2026

Open People

Log in to ask 6ix AI your own questions about ALK-abello A/S.